Kyowa Kirin, the European subsidiary of the Japan-based specialty pharmaceutical company, and University Hospitals Birmingham ...

UCB, a global biopharmaceutical company, has announced the final results from its open-label extension (OLE) study evaluating ...

Metro maps in unfamiliar cities offer a complex, often – confusing, matrix of opportunities with their twisting lines, but ...

M3 EU recently surveyed 400 pharma marketers in the UK, Germany, France and Switzerland, and here’s what we heard: Budgets ...

Medicus Pharma, a biotech and life sciences company developing novel and disruptive therapeutics, has announced the enrolment ...

Genesis Research Group is proud to be attending ISPOR Europe 2025 in Glasgow from 10-12th November with a strong scientific ...

Enterome, a clinical-stage biopharmaceutical company developing novel immunotherapies for cancer, has announced that the US ...

At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications ...

Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance ...

Pharmaceutical companies can help facilitate patient pathway stakeholder engagement by partnering with patients, providers ...

GSK has received approval from the US Food and Drug Administration (FDA) for Blenrep (belantamab mafodotin-blmf) in ...

The GPPG is more than a publication – it’s a movement towards truly patient- centric and accessible healthcare. It aims to ...